Can a phone call and online tools save lives? new study aims to boost cancer screening in High-Risk patients
NCT ID NCT07053813
First seen Feb 28, 2026 · Last updated Jun 23, 2026 · Updated 22 times
Summary
This study tests two simple, scalable methods to help people with inherited cancer risk follow through on recommended screenings. Researchers will provide online educational resources and personalized phone outreach to 900 participants. The goal is to see if these approaches improve how often people get the cancer screenings they need.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASTIC SYNDROMES, HEREDITARY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Denver Health
Denver, Colorado, 80204, United States
-
Kaiser Northwest
Portland, Oregon, 97227, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could show that simple outreach methods help people with inherited cancer risk stay on top of lifesaving screenings.
What could go wrong
This is an early-stage behavioral study, not a drug trial. The interventions may not improve screening rates, and results may not apply to other health systems.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.